baber/WOPTO huggingface dataset:
Patent NZ-567070-A (NZ)
Title: Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
Inventor: LUKER
IPC: A61K31/192
Filed: 2006-10-05
Abstract: Disclosed is a compound of formula (I), or a salt thereof, wherein Y is a bond, Z is optionally substituted aryl or heteroaryl, and the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating a disease mediated by prostaglandin D2, including respiratory diseases such as asthma or rhinitis. Also disclosed are intermediates useful for the preparation of the above compound.
Patent NZ-580750-A (NZ)
Title: System for measuring an analyte concentration in a bodily fluid sample
Inventor: EISENHARDT CHRISTOPH
IPC: G01N33/487
Filed: 2008-05-30
Abstract: System 1 for measuring an analyte concentration in a body fluid sample, comprising consumables 3 having a plurality of test fields with detection reagents that effect a detection reaction when exposed to the body fluid sample, at least one cartridge 2 that contains consumables of this type for multiple measurements, a data carrier 6 which is affixed to the cartridge 2 and contains a calibration information for the consumables 3 contained in the cartridge 2, the calibration information specifying sensitivity of a test field, and a hand-held display device 4. The display device 4 comprises a cartridge reception compartment 7 including a reading facility for receiving a cartridge 2 of this type and for reading its data carrier, a measuring facility for measuring the result of a detection reaction, a transport facility for moving consumables 3 of the cartridge 2 that is inserted in the cartridge reception compartment 7, for reception of a sample and measurement of the analyte concentration in the received body fluid sample, a processor that is connected to the measuring facility and the reading facility for controlling the measuring facility, the processor being adapted for determining a concentration value by analyzing the measuring signal and a memory that is connected to the processor and contains software for the processor. The system 1 further comprises at least one replaceable data storage unit 5 in which supplementary data is stored that functions in combination with a calibration information that is stored on the data carrier of the cartridge 2 that is inserted in the device 4 during the analysis of a measuring signal. The hand-held device 4 comprises an interface for transmission of supplementary data from the replaceable data storage unit 5 to the device 4. A consumables identification is stored on the data carrier and used by the processor after insertion of the cartridge 2 to check whether the calibration information of the data carrier affixed to the inserted cartridge 2 matches the available supplementary data and thereby to determine whether the consumables of the inserted cartridge 2 combined with the supplementary data that is available to the processor renders a reliable measurement of an analyte concentration in the body fluid sample feasible, and, if this is not the case, to generate a signal in order to indicate to a user that the available supplementary data and the consumables of the inserted cartridge 2 do not allow a valid measurement of an analyte concentration in the body fluid sample to be carried out.
Patent NZ-582577-A (NZ)
Title: In vitro method for the determination of glycemic index of food products
Inventor: MAGALETTA ROBERT L
IPC: G01N33/66
Filed: 2008-06-25
Abstract: Disclosed is an in vitro method for determining glycemic index for a test food product, said method comprising: (1) determining protein content and fat content of the test food product; (2) providing the test food product in an essentially homogeneous and finely divided state to provide a test food sample; (3) digesting an amount of the test food sample in the essentially homogeneous and finely divided state to provide a standardized amount of available carbohydrate with a mixture of digestive enzymes for a fixed period of time to provide a digested sample; (4) treating the digested sample in its entirety immediately upon the fixed period of time to stop enzymatic reactions; (5) determining amounts of glucose and at least two sugars or sugar alcohols selected from the group consisting of fructose, galactose, lactose, sucrose, and maltitol in the digestive sample from step (4); and (6) calculating the glycemic index of the test food product from data obtained in steps (1) and (5) for the test food product using a predictive equation or a predictive method derived from multivariate analysis of calibration data for calibration samples wherein the calibration data is of same type and obtained in same manner as the data for the test food product determined in steps (1) and (5) and wherein the calibration samples have known in vivo glycemic index values.
Patent NZ-589348-A (NZ)
Title: Wound dressing comprising a strip having longitudinal lines of stitches formed from a thread and transverse lines of stitches formed from a thread
Inventor: COTTON STEPHEN MICHAEL
IPC: A61F13/00
Filed: 2009-05-08
Abstract: Disclosed is a wound dressing comprising a layer in the form of a strip and comprising gel forming fibres, the strip having longitudinal lines of stitches formed from a thread and transverse lines of stitches formed from a thread, where the thread is nylon, lyocell, polyolefin, polyurethane, polyester or cellulosic.
Patent NZ-590234-A (NZ)
Title: Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
Inventor: GOMTSYAN ARTHUR
IPC: A61K31/472
Filed: 2004-06-10
Abstract: A process for preparing a compound having structural formula (1*), wherein the substituents are as defined in the specification is disclosed, wherein process (1) is a process comprising, in toto, the steps of: (a) treating a compound of formula (XII) with trichloroacetyl chloride and triethylamine in dichloromethane to provide a compound of formula (la); and (b) treating the compound of formula (la) with a compound formula (XIII) (shown in the specification) and 1,8-diazabicycloundec-7-ene (DBU) in acetonitrile to provide a compound of formula (1*). Also disclosed are alternate processes for preparing a compound of formula (1*). These compounds of formula (1*) inhibit the VR1 receptor in mammals and are useful for controlling pain.
Patent NZ-590284-A (NZ)
Title: Method for evaluating the amount of methane produced by a dairy ruminant and method for decreasing and controlling this amount
Inventor: WEILL PIERRE
IPC: A23K1/18
Filed: 2009-06-24
Abstract: Disclosed is a method of evaluating the quantity of methane that will be produced by a dairy ruminant, comprising analysing milk from the ruminant to determine what percentage of the total fatty acids in the milk consists of fatty acids with 16 carbon atoms or less (FA<C16) using the following equation: Quantity CH4 = (FA<C16/Total FAs)*a*(milk production)b wherein: quantity CH4 (in g/litre of milk) = quantity of methane produced; FA<C16 = quantity of fatty acids with 16 carbon atoms or less; Total FAs = total quantity of fatty acids; milk production = quantity of milk produced in kg of milk per animal per year; a and b are numerical parameters, with a being between 10 and 13, and b being between -0.40 and -0.45.
Patent NZ-599278-A (NZ)
Title: Methods of reducing eosinophil levels
Inventor: KOIKE MASAMICHI
IPC: A61K39/395
Filed: 2008-05-14
Abstract: NZ 599278 Disclosed is the use of a monoclonal, chimeric, humanised or human antibody that binds IL-5R in the manufacture of a medicament for treating or preventing an eosinophil mediated disease or disorder in a human subject, wherein said antibody is parenterally administered to said subject between about 0.01 to about 0.25 mg/kg, and wherein said antibody comprises an immunoglobulin Fc region comprising no fucose, and wherein the administration of the antibody reduces the number of peripheral blood eosinophils from the human subject's circulation below the limit of detection and the circulating eosinophil count level remains below detection for at least about 28 days after dosing of the antibody.
Patent NZ-599853-A (NZ)
Title: Process for the preparation of meso-N-[(3-endo)-8-benzyl-8-azabicyclo[3.2.1]oct-3-yl]acetamide and its derivatives
Inventor: BACANI GENESIS M
IPC: A61K31/4985
Filed: 2009-04-09
Abstract: Disclosed is a method for synthesizing amine E51 comprising an acetylation-reduction of oxime E41 by reacting said oxime E41 with a carboxylic acid anhydride and hydrogen in the presence of a hydrogenation catalyst.
Patent NZ-614920-A (NZ)
Title: Improved nail fastener magazine
Inventor: LIU DARREN YU JEN
IPC: F16B15/02
Filed: 2012-11-20
Abstract: A magazine for a fastener driving tool comprises a plurality of nail fasteners 10, and means for holding the plurality of nail fasteners 10 together for use with the fastener driving tool. Each nail fastener comprises a shank, a head 11 and a point 13, the head 11 being at a first end of the shank and the point 13 being at a second end of the shank distal from the first end. The plurality of nail fasteners 10 are jolt head nails or bullet head nails. The shank of each nail fastener comprises first means for resisting outward movement 14 of the nail fastener 10. The first means for resisting outward movement 14 comprises one or more ridges and/or grooves around the shank.
Patent NZ-615400-A (NZ)
Title: Vacuum assisted slot die coating techniques
Inventor: BUCILLI SERGIO
IPC: B05D1/26
Filed: 2012-04-12
Abstract: Systems, apparatuses, techniques and processes for applying a wet film (18) to a substrate (16) using a slot die (22) are provided. In one form, the air pressure around at least a portion of the discharge end of the slot die is adjustable by the application of a vacuum force (23) in order to control the width and thickness of the wet film being applied to the substrate. In one aspect of this form, the wet film is a narrow, continuous stripe of reagent material applied to a moving web of the substrate from which a plurality of test elements will be obtained. However, different forms and applications are also envisioned.
Patent NZ-617308-A (NZ)
Title: Aqueous process for preparing protein isolate and hydrolyzed protein from an oilseed
Inventor: ROZENSZAIN LUIS
IPC: C12P21/06
Filed: 2012-04-04
Abstract: A process for producing a protein isolate from an oilseed meal, comprising: -mixing an oilseed meal produced by cold pressing with an aqueous solvent to form a slurry; -optionally treating the slurry with phytase at a temperature and a pH suitable for phytase activity; -separating the slurry with a solid/liquid separation to form: i) a liquid phase, comprising the aqueous solvent, soluble protein and oil; and ii) a solid phase; -separating the liquid phase to form: i) an oil phase; and ii) an aqueous protein phase; -subjecting the aqueous protein phase to membrane filtration to obtain a protein solution; and -drying the protein solution to obtain the protein isolate, wherein the temperature in the cold pressing does not exceed 85°C.
Patent NZ-622576-A (NZ)
Title: Interchangeable lens goggle adaptable to prevent fogging
Inventor: MCCULLOCH DAVID
IPC: G02C11/08
Filed: 2012-10-17
Abstract: A goggle (700) with anti-fog, interchangeable-lens adapted for use with a battery (719). The battery provides heat through electricity to the lens to stop it from fogging up. The goggles include a body (712) with a flexible posterior portion for engaging a user’s face and an anterior portion (725); a lens (704) having a resistive anti-fog element thereon; an engagement mechanism for releasably interconnecting the lens and the body; an interconnection mechanism depending from the body adapted for detachably interconnecting the heating element of the lens and the battery; and a strap (707) adapted for holding the goggle on one of a user’s head and helmet. Removing the lens and its associated cover breaks the circuit. Different lenses can be attached for different conditions.
Patent NZ-704193-A (NZ)
Title: Aerofoil sail
Inventor: ROGERS SIMON MARK
IPC: B63H9/06
Filed: 2013-07-01
Abstract: Disclosed is an aerofoil sail for providing motive power to a waterborne vessel, the sail comprising a leading aerofoil portion and a trailing aerofoil portion, and the sail comprising a spar, at least one of the aerofoil portions rotatably positionable, and the sail comprising a controller to control individually the angular position of at least one of the aerofoil portions relative to the spar, and the spar rotationally positionable about its longitudinal axis, and wherein the leading portion is longer than the trailing portion, and a gap is provided between the leading portion and the trailing portion. Maintenance of the disclosed aerofoil sails may be enhanced as the aerofoil sails provide for internal maintenance
Patent NZ-706016-A (NZ)
Title: Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
Inventor: GOTTSCHALK STEPHEN M G
IPC: C07K19/00
Filed: 2011-10-27
Abstract: Disclosed is a chimeric antigen receptor that recognizes the CD70 antigen and that comprises the T-cell receptor CD3-ζ chain and further comprising 4-IBB.
Patent NZ-708449-A (NZ)
Title: Devices and methods for puncturing a capsule to release a powdered medicament therefrom
Inventor: ELLWANGER COLLEEN
IPC: A61M15/00
Filed: 2013-12-03
Abstract: Some medicaments are inhaled in the form of dry powders. There is a demand for better devices and methods for puncturing a capsule to release a powdered medicament therefrom. Improved approaches are needed to produce enough hole area in a capsule to allow for a full dose emission of a low density powder without the capsule being collapsed. The devices and methods of the invention allow for high doses of low-density powder to be delivered. In particular, described herein is a device (100) for puncturing a capsule (219) to release a powdered medicament therefrom which includes a chamber (210) for receiving the capsule. The capsule includes opposing domes and a cylindrical wall portion defined by a capsule wall radius r. The device further includes a mechanism (230) for puncturing at least one hole in at least one dome. A center of each hole is located within an annular puncture region situated at no less than 0.4r, and a total surface area of all puncture holes is between about 0.5% and about 2.2% of a total surface area of the capsule. The annular puncture region may, for example, be situated between about 0.4r and about 0.8r, or between about 0.4r and about 0.6r.
Patent NZ-712041-A (NZ)
Title: Marine ducted propeller jet propulsion system
Inventor: BROINOWSKI STEFAN
IPC: B63H11/117
Filed: 2014-03-17
Abstract: Marine jet propulsion poses significant design problems because of uncertain performance over a wide range of speeds, water depth, sea conditions, and excess water pickup at the jet propulsion unit inlet that may cause balling or the like. Cavitation is another problem which can be produced by excessive radial acceleration of the fluid, excess swirl and turbulence of the fluid column, and pressure changes. Thus, a jet propulsion unit for a marine vessel may include a diffuser/confusor; a steering control nozzle assembly; and a radius. The radius is introduced at a transition point between the diffuser/confusor and steering control nozzle assembly so that the diffuser/confusor can control a shape of water flow exiting the propulsion unit and can control corresponding acceleration over a large pressure differential presented by a wide range of vessel speeds, maneuvers and sea conditions.
Patent NZ-725471-A (NZ)
Title: Heat transfer fluids, systems, efficiencies, and methods
Inventor: CHAMPIE MAX
IPC: C09K5/04
Filed: 2015-06-05
Abstract: Heat transfer compositions, methods, efficiencies, and systems are disclosed. The compositions have four or more heat transfer components/constituents that have been selected such that the compositions provide an operating performance and energy efficiency that are comparable to, or better than, the performance of R22 and currently available R22 replacements. The four or more constituents have sequenced boiling temperatures that work together to extend the phase change, thereby elongating the heat absorption phase and increasing efficiency. In some embodiments the heat transfer constituents include 15-25% by weight R32, 1-5% by weight R125, 50-70% by weight R134a, and 10-20% by weight R227ea. The compositions may also include 0.5-3.5%) by weight R236.
Patent NZ-732854-A (NZ)
Title: Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
Inventor: ALAVATTAM SREEDHARA
IPC: A61K39/395
Filed: 2012-10-11
Abstract: The disclosure relates to the use of Pertuzumab, Trastuzumab and chemotherapy in the manufacture of a medicament for extending progression free survival is a HER2-positive breast cancer patient population by 6 months or more, wherein the medicament for use in a method comprising administering Pertuzumab, Trastuzumab and chemotherapy to the patients in the population, and wherein the patients in the population have a left ventricular ejection fraction (LVEF) of ≥50% at baseline.
Patent NZ-758060-A (NZ)
Title: Patient interface and method for making same
Inventor: BARBARA ANTHONY
IPC: A61M16/08
Filed: 2013-07-26
Abstract: A CPAP patient interface which seals to a patient’s nares. When the removable plenum chamber (3200) is initially secured to the frame it creates a pneumatic seal by interference from the sealing lip (3250) deflecting against the frame. When pressure within the plenum chamber is increased above atmospheric pressure for treating breathing disorders, the pneumatic seal is strengthened and increases the sealing force as the sealing lip is urged with greater force against the frame interfering portion (3314).
Patent PT-102184-A (PT)
Title: Reinforced, insulated lightweight conduit
Inventor: GOMEZ CONSTANTINO GONZALEZ
IPC: F16L9/00
Filed: 1998-07-27
Abstract: Conduit for conveying fluids, preferably liquids. It is constructed from lightweight materials and has three different elements: the inner conduit 1, the outer reinforcement 2 that is wrinkled or generated as a spiral, and an intermediate filling 3 of cellular structure 4 made from any type of appropriate material and with cells of suitable size. The conduit thus manufactured offers an increase in the capacity of its mechanical strength and greater thermal and acoustic insulation. <IMAGE>
Patent PT-105171-A (PT)
Title: Dispositivo flutuante de coluna de água oscilante para conversão da energia das ondas
Inventor: FALCAO ANTONIO FRANCO DE OLIVEIRA
IPC: F03B13/14
Filed: 2010-06-24
Abstract: O PRESENTE INVENTO REFERE-SE A UM DISPOSITIVO FLUTUANTE PARA CONVERSÃO DA ENERGIA DAS ONDAS MARÍTIMAS, DO TIPO DE COLUNA DE ÁGUA OSCILANTE COM TURBINA DE AR AUTO-RECTIFICADORA (3), PROPONDO UMA FORMA ESPECIAL DO TUBO NO INTERIOR DO QUAL SE EFECTUA O MOVIMENTO DA COLUNA DE ÁGUA. A SECÇÃO RECTA INTERIOR VARIA AO LONGO DO TUBO, SENDO MAIOR NO TROÇO INFERIOR (5) DO QUE NO TROÇO SUPERIOR (4) E COM UM TROÇO DE TRANSIÇÃO (6). NA CONFIGURAÇÃO PREFERIDA, A PAREDE (8) DO TROÇO INFERIOR DO TUBO TEM ESPESSURA SUPERIOR À REQUERIDA POR RAZÕES ESTRUTURAIS, AUMENTANDO O VOLUME, E PORTANTO A INÉRCIA, DA PARTE SUBMERSA DO CONJUNTO BÓIA-TUBO, FORMADO PELA BÓIA (1) E PELO TUBO.
Patent PT-106389-A (PT)
Title: Procedimento de congelação, descongelação e cozedura de medusas edíveis com obtenção de produto alimentar para petisco
Inventor: MORAIS ZILDA BRAGA
IPC: A23L29/275
Filed: 2012-06-20
Abstract: PROBLEMAS A RESOLVER 1. AS MEDUSAS SÃO ANIMAIS SAZONAIS, OCORREM APENAS NO VERÃO. PELOS PROCEDIMENTOS DE CONSERVAÇÃO JÁ DESCRITOS, A VIDA ÚTIL DAS MEDUSAS ARMAZENADAS NÃO ULTRAPASSA OS 12 MESES.2. A TRANSFORMAÇÃO DAS MEDUSAS ARMAZENADAS EM PRODUTO EDÍVEL RECORRE A MÉTODOS FÍSICO-QUÍMICOS DE DURAÇÃO SUPERIOR A 1 HORA. SOLUÇÃO: 1. APRESENTA-SE UM PROCESSO FÍSICO DE CONGELAÇÃO QUE NÃO ENVOLVE A INCLUSÃO DE QUALQUER ADITIVO E QUE LEVA A UMA VIDA ÚTIL DO PRODUTO SUPERIOR A 2 ANOS. 2. APRESENTA-SE UM PROCESSO EXCLUSIVAMENTE FÍSICO DE COZEDURA CUJA DURAÇÃO É INFERIOR A 15 MINUTOS.
Patent PT-117282-A (PT)
Title: Método digital sistemas gamificados para o ensino e a aprendizagem da língua estrangeira
Inventor: MARIA MANUELA LOPES ALVES DE SOUSA
IPC: G09B19/00
Filed: 2021-06-11
Abstract: O PARADIGMA DE ENSINO TRADICIONAL ASSENTA NUM CONCEITO DE APRENDIZAGEM QUE A INVESTIGAÇÃO EM CIÊNCIAS COGNITIVAS DEMONSTROU NÃO CORRESPONDER À REALIDADE DA APRENDIZAGEM E, NO CAMPO DA AQUISIÇÃO DE LÍNGUAS SEGUNDAS, A INVESTIGAÇÃO PRODUZIU NOVO CONHECIMENTO QUE GEROU MUDANÇAS SETORIAIS NO SEU ENSINO. SIMULTANEAMENTE, AS CIÊNCIAS HUMANAS TÊM-SE DEBRUÇADO SOBRE O COMPORTAMENTO HUMANO, EM ESPECIAL A MOTIVAÇÃO INTRÍNSECA, E, NOUTRAS ÁREAS, SURGIU A TEORIA DOS SISTEMAS COMPLEXOS, QUE AJUDA A ENTENDER E A LIDAR COM A COMPLEXIDADE E A MUDANÇA, ENQUANTO A TECNOLOGIA DESENVOLVEU FERRAMENTAS EXTREMAMENTE INTERESSANTES PARA O ENSINO E APRENDIZAGEM DA LÍNGUA ESTRANGEIRA; FALTA, CONTUDO, MÉTODOS DE ENSINO QUE CONFORMEM ESTA NOVA REALIDADE E SEJAM CAPAZES DE PRODUZIR A MUDANÇA NO ENSINO, QUE A ATUALIDADE RECLAMA. O MÉTODO AQUI APRESENTADO, REFLETINDO ESTE NOVO UNIVERSO CONCEPTUAL E OPERATÓRIO, DESTINA-SE AO ENSINO DA LÍNGUA ESTRANGEIRA EM AMBIENTE VIRTUAL DE APRENDIZAGEM, NUMA ABORDAGEM INTERCONECTADA E INTERATIVA DOS CONTEÚDOS.
Patent RU-94001977-A (RU)
Inventor: NIKHINSON R A
IPC: A61B17/00
Filed: 1994-01-21
Abstract: FIELD: medicine. SUBSTANCE: method involves cutting out large subcutaneous femoral vein segment to make aorta-to-splenic-artery anastomosis. EFFECT: improved blood circulation in the pancreas tail.
Patent RU-94020365-A (RU)
Inventor: MISHUSTIN V N
IPC: A61B17/00
Filed: 1994-05-31
Abstract: FIELD: medicine, phlebology. SUBSTANCE: method deals with sclerosant introduction into shin varicose vein simultaneously with conducting dosed local compression of popliteal vein in popliteal fossa at 60-70 mm mercury column pressure which should be stopped after sclerosant injection and application of compression elastic bandage onto a shin. EFFECT: improved prevention for sclerosant to be got into deep veins.
Patent RU-94021540-A (RU)
Title: Petroleum-refining plant
Inventor: ANDRIENKO V G
IPC: B01D3/04
Filed: 1994-06-17
Abstract: FIELD: petroleum-refining industry, petroleum refining with production of distillate fractions of fuel distillation and still residue. SUBSTANCE: plant additionally has a mixer of still residue of the atmospheric rectifying tower with a solid organomineral carrier, for example, sapropelite, shale, rhabdopissite, liptobiolith, sampromyxite, installed before the residual fuel oil heating furnace, thermal reactor whose inlet is connected to the outlet of the residual fuel oil heating furnace, and the outlet is connected to the separator, whose bottom through an orifice is connected to the inlet of the vacuum column or centrifuge. EFFECT: enhanced degree of extraction of white products.
Patent RU-94025927-A (RU)
Inventor: LEGAN M A
IPC: H05B7/085
Filed: 1994-07-12
Abstract: FIELD: electrometallurgy. SUBSTANCE: electrode has cylindrical graphite sections with threaded joints at ends. Electrode has extrusion-twisted material structure with least electric resistivity along helical lines. Direction of thread turns is opposing in respect to direction of these lines. Material structure imparts solenoid properties to electrode and interaction between parallel electrodes in three-phase furnace reduces side loads exerted on electrodes by electrodynamic forces and bending vibrations of electrodes. Moreover, extreme sections are influences by turn-off moment caused by interaction between magnetic field at solenoid ends and longitudinal current through extreme sections. EFFECT: improved operating reliability of threaded joints of electrode sections. 4 dwg
Patent RU-94028806-A (RU)
Inventor: KRASNOV V P
IPC: C07D401/12
Filed: 1994-08-01
Abstract: FIELD: organic chemistry. SUBSTANCE: claimed invention describes process for preparing individual stereoisomers of 4-alkylthio- and 4-heterylthio glutamic acid derivatives based on reaction of individual stereoisomer of 4-bromoglutamic acid derivatives with mercaptan salts at molar ratio thereof of 1:(2.5-3) is atmosphere of inert gas or nitrogen in ethanol-benzene mixture. EFFECT: more efficient preparation process.